Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6545 | 1403 | 39.2 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
39 | 32196 | MANTLE CELL LYMPHOMA//MYCOSIS FUNGOIDES//DIFFUSE LARGE B CELL LYMPHOMA |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MANTLE CELL LYMPHOMA | Author keyword | 575 | 62% | 42% | 594 |
2 | T1114 | Author keyword | 38 | 66% | 2% | 35 |
3 | BCL 1 | Author keyword | 28 | 60% | 2% | 31 |
4 | SOX11 | Author keyword | 22 | 52% | 2% | 30 |
5 | BLASTOID VARIANT | Author keyword | 21 | 90% | 1% | 9 |
6 | CENTROCYTIC LYMPHOMA | Author keyword | 15 | 71% | 1% | 12 |
7 | IN SITU MANTLE CELL LYMPHOMA | Author keyword | 12 | 86% | 0% | 6 |
8 | PRAD1 | Author keyword | 7 | 56% | 1% | 9 |
9 | BLASTOID | Author keyword | 7 | 64% | 0% | 7 |
10 | MANTLE CELL | Author keyword | 7 | 42% | 1% | 13 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MANTLE CELL LYMPHOMA | 575 | 62% | 42% | 594 | Search MANTLE+CELL+LYMPHOMA | Search MANTLE+CELL+LYMPHOMA |
2 | T1114 | 38 | 66% | 2% | 35 | Search T1114 | Search T1114 |
3 | BCL 1 | 28 | 60% | 2% | 31 | Search BCL+1 | Search BCL+1 |
4 | SOX11 | 22 | 52% | 2% | 30 | Search SOX11 | Search SOX11 |
5 | BLASTOID VARIANT | 21 | 90% | 1% | 9 | Search BLASTOID+VARIANT | Search BLASTOID+VARIANT |
6 | CENTROCYTIC LYMPHOMA | 15 | 71% | 1% | 12 | Search CENTROCYTIC+LYMPHOMA | Search CENTROCYTIC+LYMPHOMA |
7 | IN SITU MANTLE CELL LYMPHOMA | 12 | 86% | 0% | 6 | Search IN+SITU+MANTLE+CELL+LYMPHOMA | Search IN+SITU+MANTLE+CELL+LYMPHOMA |
8 | PRAD1 | 7 | 56% | 1% | 9 | Search PRAD1 | Search PRAD1 |
9 | BLASTOID | 7 | 64% | 0% | 7 | Search BLASTOID | Search BLASTOID |
10 | MANTLE CELL | 7 | 42% | 1% | 13 | Search MANTLE+CELL | Search MANTLE+CELL |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | EUROPEAN MCL NETWORK | 168 | 91% | 5% | 70 |
2 | CENTROCYTIC LYMPHOMA | 155 | 71% | 9% | 127 |
3 | INTERMEDIATE LYMPHOCYTIC LYMPHOMA | 129 | 75% | 7% | 94 |
4 | ZONE LYMPHOMA | 63 | 63% | 5% | 64 |
5 | MAJOR TRANSLOCATION CLUSTER | 50 | 86% | 2% | 25 |
6 | STUDY GROUP GLSG | 46 | 62% | 3% | 48 |
7 | AGGRESSIVE VARIANTS | 44 | 58% | 4% | 50 |
8 | BCL 1 REARRANGEMENTS | 42 | 94% | 1% | 15 |
9 | BCL 1 | 38 | 50% | 4% | 54 |
10 | BENDAMUSTINE PLUS RITUXIMAB | 34 | 65% | 2% | 33 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Role of allogeneic stem cell transplantation in mantle cell lymphoma | 2015 | 2 | 38 | 76% |
Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics | 2007 | 185 | 124 | 54% |
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma | 2008 | 235 | 32 | 53% |
Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era | 2011 | 116 | 117 | 47% |
Mantle-cell lymphoma | 1999 | 227 | 110 | 75% |
How I treat mantle cell lymphoma | 2009 | 76 | 79 | 84% |
Molecular pathogenesis of mantle cell lymphoma | 2012 | 44 | 99 | 65% |
How to manage mantle cell lymphoma | 2014 | 4 | 107 | 84% |
Mantle cell lymphoma - An entity comes of age | 1996 | 245 | 96 | 65% |
Current regimens and novel agents for mantle cell lymphoma | 2014 | 4 | 96 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CCG LEUKEMIA | 4 | 67% | 0.3% | 4 |
2 | DRUG DEV BRANCH | 4 | 75% | 0.2% | 3 |
3 | HEMATOPATHOL UNIT | 3 | 14% | 1.2% | 17 |
4 | HEMATOPATHOL SECTHOSP CLIN | 2 | 67% | 0.1% | 2 |
5 | MED ONCOLIRCCS | 2 | 67% | 0.1% | 2 |
6 | JOHN THEURER CANC | 2 | 12% | 0.9% | 13 |
7 | LYMPH NODE REGISTRY | 2 | 13% | 0.9% | 12 |
8 | HEMATOL 4042 | 1 | 50% | 0.1% | 2 |
9 | HOSP CLIN BARCELONA PATHOL ANAT | 1 | 100% | 0.1% | 2 |
10 | ADV THER EUT PROGRAM | 1 | 30% | 0.2% | 3 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000202726 | BENDAMUSTINE//TREANDA//BENDAMUSTIN |
2 | 0.0000193530 | SPLENIC MARGINAL ZONE LYMPHOMA//NODAL MARGINAL ZONE LYMPHOMA//MONOCYTOID B CELL LYMPHOMA |
3 | 0.0000144595 | FOLLICULAR LYMPHOMA//T1418//IN SITU FOLLICULAR LYMPHOMA |
4 | 0.0000099467 | DIFFUSE LARGE B CELL LYMPHOMA//PRIMARY MEDIASTINAL LARGE B CELL LYMPHOMA//GRAY ZONE LYMPHOMA |
5 | 0.0000087667 | FOLLICULAR LYMPHOMA//NON HODGKINS LYMPHOMA//AGGRESSIVE NON HODGKINS LYMPHOMA |
6 | 0.0000087531 | RICHTERS SYNDROME//RICHTER SYNDROME//COMPOSITE LYMPHOMA |
7 | 0.0000084704 | BIOMED 2//TREPHINE BIOPSY//BONE MARROW BIOPSY |
8 | 0.0000078440 | CHRONIC LYMPHOCYTIC LEUKEMIA//CLL//B CLL |
9 | 0.0000074735 | MALT LYMPHOMA//GASTRIC LYMPHOMA//GASTRIC MALT LYMPHOMA |
10 | 0.0000073424 | CYCLIN D1//CYCLIN E//CCND1 |